Fate Therapeutics News

Fate Therapeutics | 8-K: Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

May 10 04:08

Fate Therapeutics | 8-K: Current report

May 9 21:02

Fate Therapeutics | DEF 14A: Definitive information statements

Apr 27 04:35

Fate Therapeutics | DEFA14A: Others

Apr 27 04:28

Fate Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Apr 19 04:03

Fate Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 17 04:11

Fate Therapeutics | 8-K: Current report

Mar 22 02:52

Fate Therapeutics | 8-K: Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

Feb 27 05:09

Fate Therapeutics | 8-K: Current report

Nov 9, 2023 06:10

Fate Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Nov 9, 2023 05:44

Fate Therapeutics | 8-K: Fate Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates

Nov 9, 2023 05:03

Fate Therapeutics | 8-K: Current report

Sep 2, 2023 05:29

Fate Therapeutics | 8-K: Fate Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates

Aug 9, 2023 04:07

Fate Therapeutics | 8-K: Current report

Jun 10, 2023 04:08

Fate Therapeutics | 8-K: Current report

Jun 9, 2023 04:12

Fate Therapeutics | 8-K: Current report

Jun 7, 2023 20:52

Fate Therapeutics | 8-K: Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates

May 4, 2023 04:06

Fate Therapeutics | DEFA14A: Others

Apr 22, 2023 04:05

Fate Therapeutics | DEF 14A: Definitive proxy statements

Apr 22, 2023 04:04

Fate Therapeutics | 8-K: Current report

Apr 20, 2023 04:06